These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 8913544

  • 1. Antihypertensive efficacy of the angiotensin II AT1-receptor antagonist losartan: results of a randomized, double-blind, placebo-controlled, parallel-group trial using 24-hour blood pressure monitoring. Ambulatory Blood Pressure Monitoring Study Group.
    Byyny RL.
    Blood Press Suppl; 1996; 2():71-7. PubMed ID: 8913544
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg AI, Nelson EB.
    Arch Intern Med; 1995 Feb 27; 155(4):405-11. PubMed ID: 7848024
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
    Mallion JM, Goldberg AI.
    Blood Press Suppl; 1996 Feb 27; 2():82-6. PubMed ID: 8913546
    [Abstract] [Full Text] [Related]

  • 5. Controlling blood pressure throughout the day: issues in testing a new anti-hypertensive agent.
    Weber MA, Neutel JM, Smith DH.
    J Hum Hypertens; 1995 Nov 27; 9 Suppl 5():S29-35. PubMed ID: 8583478
    [Abstract] [Full Text] [Related]

  • 6. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension.
    Ogihara T, Yoshinaga K.
    Blood Press Suppl; 1996 Nov 27; 2():78-81. PubMed ID: 8913545
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar 27; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of losartan.
    Goldberg A, Sweet C.
    Can J Cardiol; 1995 Aug 27; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [Abstract] [Full Text] [Related]

  • 9. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
    Arch Mal Coeur Vaiss; 2001 Aug 27; 94(8):907-12. PubMed ID: 11575229
    [Abstract] [Full Text] [Related]

  • 10. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW, Lacourcière Y, Barnes CC.
    CMAJ; 1998 Sep 08; 159(5):469-76. PubMed ID: 9757170
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
    Clin Ther; 2006 Oct 08; 28(10):1639-48. PubMed ID: 17157119
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B, Brunner HR.
    Br J Clin Pract; 1996 Oct 08; 50(5):265-8. PubMed ID: 8794603
    [Abstract] [Full Text] [Related]

  • 16. Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of manidipine hydrochloride 10, 20 or 40 mg once daily as compared to placebo in treating mild to moderate essential hypertension: a double-blind, randomized, parallel group, placebo-controlled study.
    Fogari R, Zoppi A, Lusardi P, Preti P, Poletti L, Mugellini A.
    Blood Press Suppl; 1996 Oct 08; 5():16-23. PubMed ID: 8973788
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 08; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 18. Losartan with hydrochlorothiazide in the treatment of hypertension.
    Schoenberger JA, Losartan Research Group.
    J Hypertens Suppl; 1995 Jul 08; 13(1):S43-7. PubMed ID: 18800455
    [Abstract] [Full Text] [Related]

  • 19. [Antihypertensive effect of a non-peptide angiotensin II receptor antagonist, MK954, in patients with essential hypertension].
    Hagino T, Abe K, Tsunoda K, Yoshinaga K.
    Nihon Jinzo Gakkai Shi; 1992 Feb 08; 34(2):133-40. PubMed ID: 1588765
    [Abstract] [Full Text] [Related]

  • 20. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
    Byyny RL, Merrill DD, Bradstreet TE, Sweet CS.
    Cardiovasc Drugs Ther; 1996 Jul 08; 10(3):313-9. PubMed ID: 8877074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.